Work and Cancer — Free, Virtual Conference, June 24, 2022

June 13, 2022

Join Cancer + Careers when they present the 12th Annual National Conference on Work and Cancer on Friday, June 24, 2022.  This free, virtual, day-long event is open to patients, caregivers, healthcare professionals, advocates, employers/HR and …


Ask the NET Expert – May 2022

June 6, 2022
Ask the NET Expert — A New Web-Based Program

The Carcinoid Cancer Foundation is excited to have launched a new web-based program for the neuroendocrine tumor (NET) community – Ask the NET Expert. Each month, we are featuring a different physician who …


SNMMI Patient Education Day — Hybrid (In-Person and Virtual)

June 2, 2022

The Society of Nuclear Medicine and Molecular Imaging will offer a special Patient Education Day on Sunday, June 12 as part of its 2022 Annual Meeting. This free event offers patients and caregivers a unique opportunity to learn about the role of nuclear…


New Appointment for NET Expert Dr. Boris Naraev

March 20, 2022

Congratulations to Dr. Boris Naraev upon being appointed Medical Oncology Leader – Gastrointestinal, Neuroendocrine, and Rare Cancers Program at the Anderson Family Cancer Institute in Jupiter, Florida. Dr. Naraev previously led the Neuroendocrine…


The Passing of Dr. Thomas O’Dorisio

February 10, 2022

It is with great sadness that we share the passing of Dr. Thomas O’Dorisio, a pioneer and leader in the field of neuroendocrine cancer; a compassionate and dedicated physician; an outstanding colleague at the University of Iowa; and beloved husband to…


New NET Research Collaboration

February 10, 2022

Exciting news about a new research collaboration to discover and develop novel therapies targeting immune checkpoint proteins for the treatment of neuroendocrine tumors and other cancers.  The collaboration was announced by NexImmune Inc., a clinical-stage…


Second Generation Immunohistochemical Markers: Reflections from Clinical Implementation

February 3, 2022

This article from pathologist Carl Christofer Juhlin, MD, PhD, of Karolinska Institutet in Sweden identifies second-generation neuroendocrine immunohistochemical markers.   These markers can help identify the site of primary neuroendocrine…


New Online Survey For Carcinoid Syndrome Patients, Open Through February 12

February 1, 2022

You can make a difference in how a clinical trial is designed! Share your thoughts today by participating in a new survey for neuroendocrine cancer patients with Carcinoid Syndrome. The survey will be online through February 12. Read more here,…/13668e89c4ceb31e31b3598f2f3b10f1


Loving Lemons Even When You Wanted Oranges

January 5, 2022

In a feature article in Oncology Fellows, neuroendocrine cancer expert Robert Ramirez, DO, FACP, describes his path to clinical thoracic oncology after originally planning on entering the field of academics early in his career.  Dr. Ramirez is Associate…


2021 Monica Warner Award: Call for Nominations — Deadline January 21, 2022

December 22, 2021

Advanced Accelerator Applications (AAA), a Novartis company, has announced that nominations are open for the 12th Annual Monica Warner Award!  AAA is continuing the Novartis tradition of sponsoring the award, which commemorates the life and work…